hydroxyindoleacetic acid has been researched along with u-50488 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Althaus, JS; Donzanti, BA; Payson, MM; Von Voigtlander, PF | 1 |
Leyton, M; Rajabi, H; Stewart, J | 1 |
Devine, DP; Leone, P; Pocock, D; Wise, RA | 1 |
Martín, MI; Milanés, MV; Ormazábal, MJ | 1 |
4 other study(ies) available for hydroxyindoleacetic acid and u-50488
Article | Year |
---|---|
Kappa agonist-induced reduction in dopamine release: site of action and tolerance.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Analgesics; Animals; Dopamine; Drug Tolerance; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Nucleus Accumbens; Perfusion; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 1992 |
U-50,488H into A10 reduces haloperidol-induced elevations of accumbens dopamine.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Analgesics; Animals; Dialysis; Dopamine; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; Nucleus Accumbens; Pyrrolidines; Rats; Rats, Wistar | 1992 |
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Amino Acid Sequence; Analgesics; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Homovanillic Acid; Hydroxyindoleacetic Acid; Limbic System; Male; Microinjections; Molecular Sequence Data; Naltrexone; Narcotic Antagonists; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Tegmentum Mesencephali | 1993 |
Serotonergic mechanisms involved in calcitonin potentiation of kappa-opioid receptor-mediated effects on adrenal secretion.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 5-Hydroxytryptophan; Analgesics, Non-Narcotic; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Calcitonin; Corticosterone; Enzyme Inhibitors; Hydrazines; Hydroxyindoleacetic Acid; Hypothalamo-Hypophyseal System; Male; Monoamine Oxidase Inhibitors; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Pituitary Hormone-Regulating Hormone; Serotonin; Tranylcypromine | 1997 |